The first Bio-Rad Laboratories trade was made in Q4 2022. Since then Jefferies Group bought shares two more times and sold shares on seven occasions. The investor completely sold their stake between Q4 2024 and Q1 2025.
Identity, Access Management Solutions Provider BIO-key to Participate in Fireside Chat at the Maxim Group Virtual Tech Conference, Tues. June 4th at 9am ET
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics products, today announced that Anette Eng...
HERCULES, Calif.--(BUSINESS WIRE)--Bio-Rad Laboratories, Inc. (NYSE: BIO and BIO.B), a global leader in life science research and clinical diagnostics produc...
Major players in the stem cell assay market are Thermo Fisher Scientific Inc. , Merck Group, Danaher Corporation, Becton Dickinson and Company, Bio-Rad Labor...